Blood biomarkers to distinguish complicated and uncomplicated appendicitis in pediatric patients

Siu Chung Ha1, Ya-Hui Tsai2, Chee-Chee Koh3

  • 1Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, New Taipei, 220, Taiwan; Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li, Taoyuan 320, Taiwan.

Insights

C-reactive protein (CRP) effectively distinguishes complicated appendicitis from uncomplicated appendicitis in children. This blood biomarker aids in early diagnosis and management of acute appendicitis, improving patient outcomes.

Area of Science:

  • Pediatric Surgery
  • Diagnostic Biomarkers
  • Inflammatory Markers

Background:

  • Acute appendicitis is a common cause of pediatric abdominal pain.
  • Distinguishing complicated appendicitis (CA) from uncomplicated appendicitis (UA) is crucial for patient management.
  • Early and accurate diagnosis of appendicitis is essential to prevent increased morbidity.

Purpose of the Study:

  • To evaluate the diagnostic utility of blood biomarkers in differentiating CA from UA in pediatric patients.
  • To identify specific inflammatory markers that can predict the progression of appendicitis.

Main Methods:

  • Retrospective review of 192 pediatric patients with appendicitis.
  • Categorization into UA and CA groups based on histopathology.
  • Analysis of white blood cell count, neutrophil and lymphocyte proportions, NLR, MLR, PLR, and CRP levels.

Main Results:

  • Patients with CA showed higher neutrophil proportions, NLR, PLR, and CRP levels compared to UA patients.
  • Lower lymphocyte proportions were observed in the CA group.
  • C-reactive protein (CRP) demonstrated the highest specificity, sensitivity, and predictive values for CA detection via ROC analysis.

Conclusions:

  • C-reactive protein (CRP) is a valuable biomarker for differentiating complicated appendicitis from uncomplicated appendicitis in pediatric cases.
  • CRP aids in the early identification of severe appendicitis, guiding timely surgical intervention.
Abstract

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
80
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
145
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
158
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
348
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334